Contributor Page
Ernst & Young LLP
 
Email  |  Articles
Contact Details
Tel: +1 312 8796968
Fax: +1 866 8739745
Sears Tower
233 South Wacker Drive
Chicago
Illinois
IL 60606-6301
United States
By William Henderson
The world is getting smaller and the reality of a truly global marketplace now puts the spotlight on less-than-honorable business practices that have for so long inhibited growth in the developing world. This is a very positive forward movement for growing economies.
The catastrophic losses resulting from the terrorist attacks of 9/11 and Hurricane Katrina highlighted many of the issues that face policyholders in the wake of a disaster.
A lively roundtable discussion featuring FIDS executive Jack Holleran focuses on compliance programs, the investigation of compliance violations, and civil and criminal defense.
By Bradley Massam, Walter Morris
The Editor interviews Bradley Massam and Walter Morris of Ernst & Young’s Fraud Investigation & Dispute Services practice. Mr. Massam is a Partner and serves as Americas Leader for Financial Services.
As companies continue to expand their presence around the globe, the number of completed cross-border mergers and acquisitions has soared.
In the wake of corporate scandals and high-profile prosecutions, many companies have avoided prosecution or have otherwise negotiated reduced sanctions in recent years by cooperating with prosecutors or regulators and entering into agreements that often include accepting a monitor.
Recent media reports highlight a number of significant business transactions gone awry, with the collapse of Sallie Mae’s sale to JC Flowers – the most recent failed mega buyout.
By Eric Schwarz, Vincent Walden
After several high-profile court decisions and, more recently, the imposition of the amended Federal Rules of Civil Procedure relating to electronic evidence, attorneys and their clients are now more than ever under pressure to manage discovery of electronic evidence correctly in any litigation, regulatory inquiry or law enforcement matter.
By Ted Acosta, Eileen Erdos
The rising cost of medications, a shortage of healthcare funding and prolific media coverage continue to sharpen the focus of lawmakers, regulators and enforcement authorities on the activities of the pharmaceutical industry.
By Bobbi Basile, David Wetmore
The newly enacted amendments to the Federal Rules of Civil Procedure have had the legal community abuzz for months as lawyers, both in-house and outside, have worked to determine what the revisions mean to them.
By Eric Schwarz, Vincent Walden
After several high-profile court decisions and, more recently, the imposition of the amended Federal Rules of Civil Procedure relating to electronic evidence, attorneys and their clients are now more than ever under pressure to manage discovery of electronic evidence correctly in any litigation, regulatory inquiry, or law enforcement matter.
By Jack Holleran, Jerry Wald
Companies confront a broad scope of risks, from compliance matters and regulatory risk to threats to the business itself and to its reputation.
By Gregory Wolski
Over the past year, acquisitive companies have increasingly seen the mergers and acquisitions market become stronger and more competitive. While this is good news on many fronts, it also can signal heightened opportunity for disputes to arise in the wake of a deal.
By Eric Schwarz, David Wetmore
While lawyers across the country have been concerned about electronic discovery and its implications for several years now, recent court judgements have made this a significant financial issue as well. A $1.45 billion verdict is quite an attention-getter when it comes to the potential consequences of discovery failures.
By Ted Acosta
In February 2006, local newspapers in the United Kingdom reported on disciplinary judgments made by the Association of the British Pharmaceutical Industry (ABPI) against four pharmaceutical manufacturers. The disciplinary judgments consisted of public reprimands for three companies, and suspension from the association for a period of at least six months for the fourth company.